New Articles  

Section "News":

Section "News":

Section "News":

Section "News":

Home Page Send a Message Switch to English Russian

Association of Clinical Trials Organizations (ACTO)
non-commercial organization of the companies/ legal entities and clinical research community engaged in clinical trials in Russia.

New articles

Subsection "Structure of CT market" added information for the year 2023. read more »

The annual General Meeting of ACTO approved 2023 Report on Activities and the Board members for 2024. read more »

ACTO Newsletter 27 about 1st Half of 2023 is published. read more »

Clinical Trials in Russia

ACTO was duly established at the end of November 2007 as non-commercial organization of the companies/ legal entities and clinical research community engaged in clinical trials in Russia. The situation involving the export of biological samples, which occurred in May 2007, was the stimulus that led companies to create the Association. At that time there was a lack of uniting power, to appeal on behalf of business.

The primary objectives of the Association are to further develop Russia as clinical research country/market, to ensure a proper and effective balance between the interests of parties involved in clinical trials including the patients, the medical community, and the governmental agencies, to harmonize local legislative basis for the clinical trials with the respective worldwide standards, and to promote an ethical business model.

To date, ACTOs members are 16 pharmaceutical companies, contract research organizations and a company providing supply chain solutions for clinical trials: Almedis, Bayer, Boehringer Ingelheim, Fortrea, ICON, IQVIA, Janssen Pharmaceutica, KCR, Novartis, Novo Nordisk, Parexel, Pfizer, PPD, PSI, Servier, Worldwide Clinical Trials (WCT).

Each ACTOs member conducts clinical trials in accordance with international standard of Good Clinical Practice (ICH GCP). In accordance with the Statutes of Association ACTOs members should follow the principles of integrity, respect for other market participants, and not admit cases of unfair competition.

ATO performs its activities through three committees set up on the most important areas:

  • Promotion of the optimization of regulatory authorities work (Regulatory committee);
  • Analysis and development of solutions to logistical problems encountered in conducting clinical trials (Committee on logistics);
  • Analysis of market initiatives to change legislation and developmentof Association proposals to improve the legal framework (Legislative committee).
  • To address urgent challenges ACTO creates working groups.

The Association invites organizations, associations and institutes engaged in clinical trials activities in Russia for partnering.

Rambler's Top100